The Lung Microbiome in Idiopathic Pulmonary Fibrosis: A Promising Approach for Targeted Therapies.

MLA

Fastrès, Aline, et al. “The Lung Microbiome in Idiopathic Pulmonary Fibrosis: A Promising Approach for Targeted Therapies.” International Journal of Molecular Sciences, vol. 18, no. 12, Dec. 2017. EBSCOhost, https://doi.org/10.3390/ijms18122735.

APA

Fastrès, A., Felice, F., Roels, E., Moermans, C., Corhay, J.-L., Bureau, F., Louis, R., Clercx, C., & Guiot, J. (2017). The Lung Microbiome in Idiopathic Pulmonary Fibrosis: A Promising Approach for Targeted Therapies. International Journal of Molecular Sciences, 18(12). https://doi.org/10.3390/ijms18122735

Chicago

Fastrès, Aline, Florence Felice, Elodie Roels, Catherine Moermans, Jean-Louis Corhay, Fabrice Bureau, Renaud Louis, Cécile Clercx, and Julien Guiot. 2017. “The Lung Microbiome in Idiopathic Pulmonary Fibrosis: A Promising Approach for Targeted Therapies.” International Journal of Molecular Sciences 18 (12). doi:10.3390/ijms18122735.